Profit on $475,000 Novartis cancer drug could be a while coming
Swiss company has been criticised for its ‘excessive’ pricing of Kymriah
Swiss company has been criticised for its ‘excessive’ pricing of Kymriah
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices